1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Venous Thromboembolism

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Venous Thromboembolism in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
He, XL; Qiu, H; Sun, XW; Wang, YH	1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Venous Thromboembolism

Article	Year
Prevention of venous thromboembolism after resection of primary liver cancer with low molecular weight heparin and its association with P-selectin, lysosomal granule glycoprotein, platelet activating factor and plasma D-dimer. European review for medical and pharmacological sciences, 2018, Volume: 22, Issue:14 Topics: Adult; Aged; Female; Fibrin Fibrinogen Degradation Products; Heparin, Low-Molecular-Weight; Humans; Liver Neoplasms; Male; Middle Aged; P-Selectin; Platelet Activating Factor; Tetraspanin 30; Venous Thromboembolism	2018

Article

Year

Prevention of venous thromboembolism after resection of primary liver cancer with low molecular weight heparin and its association with P-selectin, lysosomal granule glycoprotein, platelet activating factor and plasma D-dimer.

European review for medical and pharmacological sciences, 2018, Volume: 22, Issue:14

Topics: Adult; Aged; Female; Fibrin Fibrinogen Degradation Products; Heparin, Low-Molecular-Weight; Humans; Liver Neoplasms; Male; Middle Aged; P-Selectin; Platelet Activating Factor; Tetraspanin 30; Venous Thromboembolism

2018